US Stock MarketDetailed Quotes
RLMD Relmada Therapeutics
- 2.300
- -0.940-29.01%
Close Aug 8 16:00 ET
- 2.380
- +0.080+3.48%
Post 16:51 ET
69.40MMarket Cap-801P/E (TTM)
3.240High2.250Low730.78KVolume3.210Open3.240Pre Close1.92MTurnover2.63%Turnover RatioLossP/E (Static)30.17MShares7.22352wk High1.13P/B63.85MFloat Cap2.25052wk Low--Dividend TTM27.76MShs Float54.000Historical High--Div YieldTTM30.56%Amplitude1.810Historical Low2.621Avg Price1Lot Size
Relmada Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Aug 8, 2024
The average Relmada Therapeutics stock price target is 13.50 with a max estimate of 25.00 and a min estimate of 2.00
Review Relmada Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Aug 8, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg